Trial intelligence / Profile preview

Vaginal Estrogen Cream for Ring Pessary Use in Pelvic Organ Prolapse

NCT04393194Phase 4Unknown

Sponsor
Peking Union Medical College Hospital
Start
May 2020
Primary completion
Jun 2022
01

Overview

Phase 4, randomised, double-blind trial of conjugated estrogens vaginal cream in pelvic organ prolapse (POP) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Patient Global Impression of Improvement at 1 year. Status: unknown.

02

Drugs

conjugated estrogens vaginal cream
03

Conditions

pelvic organ prolapse (POP)

Beyond the preview

Go deeper on NCT04393194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04393194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call